Member Info for doze

GDG have the option to tie into cnooc ' Option for GDG to deliver gas directly into CUCBM infrastructure' so maybe not so much demand for gas to liquid plant of GEL also the 'partner would encourage this so not that happy myself.

http://www.tyratech.com/content/company-products/head-lice.asp

http://www.londonstockexchange.com/exchange/news/market-news/market-news-detail.html?announcementId=11909867 The following link which is in the rns shows a daily use version of Vamousse to prevent reinfection of headlice which grateful users might well take to using. Still another 4000 US Walmarts to stock.

http://www.londonstockexchange.com/exchange/news/market-news/market-news-detail.html?announcementId=11904064

Status may be reinstated if OXT reduce Scancell to 15% of vct. Tax break is to encourage investment in aim and non quoted business so obviously a limit is placed with the intention that successful investments will result in return to investors or a bigger spread of companies to benefit from vct money, sitting on the gain is not following the rules. Octopus had to sell zoopla and reconfigure vcts or they might have fallen foul but they took action.

http://finance.yahoo.com/echarts?s=%5ENBI+Interactive#symbol=^nbi;range=5y;compare=;indicator=volume;charttype=area;crosshair=on;ohlcvalues=0;logscale=off;source=; Seems Scott has timed his move just as a bubble may be bursting in the biotechs there while biotechs in the UK are perhaps showing signs of life with new floats coming up. After our three month lock out as existing UK holders lets hope a stable market in XBIO has been established because I have a sensible-maybe- plan in mind!

http://www.londonstockexchange.com/exchange/news/market-news/market-news-detail.html?announcementId=11887826 Good outlook for the future of TRT if you rate Octopus, http://www.octopusinvestments.com/investors/shareholder-information/titan-vct-1/ 34p special div last year.

Verizon Communications netted $193.93, based on dividends plus mean target price estimate from twenty-five analysts less broker fees. The Beta number showed this estimate subject to volatility 95% less than the market as a whole. http://seekingalpha.com/article/2054253-9-dogs-of-the-dow-seek-10-percent-to-17-percent-february-upsides?source=email_rt_mc_related_0

http://www.eservglobal.com/system/files/eServGlobal_Annual_Report_FY2013.pdf

http://www.londonstockexchange.com/exchange/news/market-news/market-news-detail.html?announcementId=11874818

Perhaps riddler could confirm if this is a rerating share at the moment?

After reading this post I am glad I recommended your history post. It read as a very knowledgeable post and great summary/research on the company, thanks a lot comzzz. I am in coms too.

In a t/o situation they would both be worth the same.

Vol / Avg. 6.57M/159,933.00

No market exists for the trading of the Common Shares in the United States and none is expected to develop. The Common Shares purchased by US persons will be ''restricted securities'' as defined in Rule 144 under the Securities Act and may not be resold in the United States absent registration under the Securities Act and any applicable US state securities laws or pursuant to exemptions from the Securities Act and such laws. The Company does not intend to register the Common Shares under the Securities Act or any US state securities laws.

Sorry, Chairman

Probably anticipation of a bigname CEO appointed, lets hope...

well timed buy Wolfe

http://www.londonstockexchange.com/exchange/news/market-news/market-news-detail.html?announcementId=11862745 disappointing news but good trading will see the SP respond, not many early sells on this news which is a good sign.

http://www.londonstockexchange.com/exchange/news/market-news/market-news-detail.html?announcementId=11861151